Wearable real-time drug monitor for personalized addiction treatment
Official title: A Wearable Continuous Polydrug Monitor (CPM) for Personalized SUD Treatment
Funded at Labsys, LLC · NIH-11406706 · Data updated 2026-11-12
A wearable device continuously tracks fentanyl and other substances to help tailor medications and support for people with substance use disorders.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Labsys, LLC NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project start | August 15, 2026 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $302,225 |
| NIH project number | 1R44DA066336-01 |
| Project ID | NIH-11406706 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with substance use disorders who are undergoing treatment and could benefit from continuous drug monitoring.
✕Less likely to help
Individuals without SUD or those not engaged in treatment may not benefit from this device.
What this research studies
This project aims to bring a wearable sensor into outpatient care that monitors drugs in real-time, so clinicians can respond quickly to relapse risks. The device uses a thin, low-power sensor to detect fentanyl and other high-risk substances in interstitial fluid and shares results to guide treatment decisions. The goal is to improve adherence, reduce barriers like costs and stigma, and enable more timely, personalized interventions. It emphasizes real-time data integration to streamline clinical workflows and support safer, more effective care outside the clinic.
Why it matters
Potential benefit: If successful, patients could receive more timely support and better treatment adjustments, potentially reducing overdose risk.
How similar studies have gone: Prior wearable sensors showed promise but lacked continuous, substance-specific detection in real-world use.
Where this research is happening
-
Labsys, LLC
East Lansing, United States Active
Researchers
- Principal investigator: Huang, Yue — Labsys, LLC
- Study coordinator: Huang, Yue
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.